8-K: National Health Investors CEO Secures Change in Control Severance

National Health Investors, Inc. has entered into a Change in Control Severance Agreement with executive Todd Siefert, effective July 1, 2026, outlining benefits in the event of termination following a change in control.

Summary

• National Health Investors, Inc. (the Company) has established a Change in Control Severance Agreement with Todd Siefert, effective July 1, 2026.
• This agreement provides specific severance benefits to the Executive if their employment is terminated by the Company without Cause or by the Executive for Good Reason within two years following a Change in Control.
• It also covers termination without Cause within 30 days prior to a Change in Control.
• Severance includes a lump sum cash payment of 2.0 times the average of the Executive's base salary and bonus for the most recent two years (or fewer if employed for less time).
• An additional lump sum payment equal to the greater of the target annual bonus or the earned pro-rated bonus is also included.
• The Executive will receive 18 months of continued COBRA coverage for themselves and their dependents.
• All equity or equity-based incentive awards subject solely to time-based vesting will vest immediately.
• The agreement includes non-competition and non-solicitation restrictions for 12 months post-termination if severance is paid, along with ongoing confidentiality restrictions.
• Payments will be reduced to avoid excise taxes under Section 4999 of the Code if such reduction results in a greater net after-tax benefit for the Executive.
• The full agreement is filed as Exhibit 10.1.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details a standard executive severance agreement rather than providing new financial performance data or strategic operational updates.

Positives

• Provides financial security and clarity for executive Todd Siefert in the event of a change in control.
• Ensures continued healthcare coverage for the executive and their family for 18 months post-termination.
• Accelerated vesting of equity awards provides immediate benefit to the executive.
• Non-compete and non-solicitation clauses offer protection to the company.
• The agreement aims to ensure the executive receives the maximum net after-tax proceeds by managing potential excise taxes.

Negatives

• The agreement implies a potential for a change in control, which could introduce uncertainty for the company and its stakeholders.
• The severance package represents a significant potential financial obligation for the company in the event of a change in control and termination.
• The non-compete and non-solicitation clauses, while protective, could limit the executive's future employment options.

Risks

• Potential for a change in control event, which could lead to operational disruption and strategic shifts.
• Financial risk to the company associated with the severance payout if a change in control and termination occurs.
• The executive's ability to seek new employment may be restricted by non-compete and non-solicitation clauses.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding future financial performance. The primary focus is on the terms of the severance agreement.

Industry Context

StockSavvy.ai notes that change in control severance agreements are common in the healthcare REIT sector, particularly for senior executives, as they aim to retain key talent and provide security during potential M&A activities or significant strategic shifts within the industry.

Management Changes

Stakeholder Impact

• Shareholders: May be concerned about potential future costs associated with severance payouts if a change in control occurs.
• Employees: The agreement may signal potential organizational changes or M&A activity, creating uncertainty.
• Executive (Todd Siefert): Receives enhanced financial security and benefits in specific termination scenarios.

Next Steps

• The full text of the Change in Control Severance Agreement is available as Exhibit 10.1.

Key Dates

Keywords

Change in Control, Severance Agreement, Executive Compensation, Todd Siefert, National Health Investors, Corporate Governance, Employee Benefits, Termination, Non-Compete, Non-Solicitation